Bernstein raised the firm’s price target on Intuitive Surgical (ISRG) to $740 from $700 and keeps an Outperform rating on the shares. After a low point in September 2025, U.S. healthcare stocks have begun to perform better over the past several months, the firm notes. As the market gets more clarity on many of the macro / policy uncertainties that weighed on healthcare stocks during the course of 2025, Bernstein anticipates better days ahead for healthcare stocks in 2026.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- AIQ vs. BOTZ vs. ARTY: Which AI ETF Is the Best Buy for 2026?
- Intuitive Surgical price target raised to $714 from $621 at Goldman Sachs
- Intuitive Surgical price target raised to $616 from $589 at BTIG
- U.S. Chess Champion is Bullish on These Two New Stocks – ASTS and SNDK
- Intuitive Surgical price target raised to $686 from $635 at Barclays